HK1059773A1 - Suplatast tosilate crystals. - Google Patents

Suplatast tosilate crystals.

Info

Publication number
HK1059773A1
HK1059773A1 HK04102618A HK04102618A HK1059773A1 HK 1059773 A1 HK1059773 A1 HK 1059773A1 HK 04102618 A HK04102618 A HK 04102618A HK 04102618 A HK04102618 A HK 04102618A HK 1059773 A1 HK1059773 A1 HK 1059773A1
Authority
HK
Hong Kong
Prior art keywords
suplatast tosilate
crystal
tosilate crystals
suplatast
tosilate crystal
Prior art date
Application number
HK04102618A
Other languages
English (en)
Inventor
Takanori Ushio
Hidenori Miura
Keiko Nagai
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of HK1059773A1 publication Critical patent/HK1059773A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C07C381/12Sulfonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
HK04102618A 2001-04-16 2004-04-15 Suplatast tosilate crystals. HK1059773A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001117165 2001-04-16
PCT/JP2002/003762 WO2002083633A1 (fr) 2001-04-16 2002-04-16 Cristaux de tosilate de suplatast

Publications (1)

Publication Number Publication Date
HK1059773A1 true HK1059773A1 (en) 2004-07-16

Family

ID=18967782

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04102618A HK1059773A1 (en) 2001-04-16 2004-04-15 Suplatast tosilate crystals.

Country Status (16)

Country Link
US (1) US7138140B2 (fr)
EP (1) EP1295870B1 (fr)
JP (1) JP4015954B2 (fr)
KR (1) KR100535305B1 (fr)
CN (1) CN1205182C (fr)
AT (1) ATE381538T1 (fr)
AU (1) AU2002248036B2 (fr)
CA (1) CA2413087C (fr)
CY (1) CY1107112T1 (fr)
DE (1) DE60224145T2 (fr)
DK (1) DK1295870T3 (fr)
ES (1) ES2298358T3 (fr)
HK (1) HK1059773A1 (fr)
PT (1) PT1295870E (fr)
TW (1) TWI241289B (fr)
WO (1) WO2002083633A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005260954B2 (en) * 2004-07-13 2011-04-07 Taiho Pharmaceutical Co., Ltd. Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same
JP4794148B2 (ja) * 2004-09-10 2011-10-19 大鵬薬品工業株式会社 ネフローゼ症候群治療剤
JP4498101B2 (ja) * 2004-11-04 2010-07-07 大鵬薬品工業株式会社 頭痛の予防及び/または治療剤
WO2007001058A1 (fr) * 2005-06-27 2007-01-04 Juntendo Educational Foundation Agent thérapeutique dérivé de l'herpèsvirus contre la douleur
EP2103305B1 (fr) * 2006-12-26 2011-09-28 Taiho Pharmaceutical Co., Ltd. Agent therapeutique pour neuropathie diabetique
CA3073866A1 (fr) * 2017-08-29 2019-03-07 Conrig Pharma Aps Composition comprenant du tosilate de suplatast
EP3813817A4 (fr) * 2018-06-27 2022-08-10 Algernon Pharmaceuticals Inc. Utilisation d'actarit dans la prophylaxie ou le traitement d'une fibrose rénale ou d'une maladie rénale
CN110824088B (zh) * 2019-11-26 2022-04-12 重庆柳江医药科技有限公司 利用hplc-ms测定甲磺司特在血浆中含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556737A (en) * 1983-03-11 1985-12-03 Taiho Pharmaceutical Company Limited Sulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the same
DE4107857A1 (de) * 1991-03-12 1992-09-17 Thomae Gmbh Dr K Cyclische harnstoffderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
TW264385B (fr) * 1993-05-14 1995-12-01 Taiho Pharmaceutical Co Ltd
JP3256376B2 (ja) * 1994-01-27 2002-02-12 大鵬薬品工業株式会社 トシル酸スプラタストの結晶およびその製造方法
JP3563480B2 (ja) 1994-03-10 2004-09-08 大鵬薬品工業株式会社 光学活性体の製造方法、並びに光学活性なスルホニウム化合物
CA2192576A1 (fr) * 1995-04-24 1996-10-31 Fuminori Tokumochi Remede pour maladies allergiques, a appliquer dans la region du nez
US5965565A (en) * 1996-12-12 1999-10-12 Merck & Co., Inc. Piperidines promote release of growth hormone
JP3634622B2 (ja) 1998-05-01 2005-03-30 大鵬薬品工業株式会社 腎透析に伴うそう痒の治療剤
WO2000027383A1 (fr) * 1998-11-05 2000-05-18 Taiho Pharmaceutical Co., Ltd. Medicaments contre la dysurie

Also Published As

Publication number Publication date
WO2002083633A1 (fr) 2002-10-24
PT1295870E (pt) 2008-01-10
AU2002248036B2 (en) 2005-04-21
ATE381538T1 (de) 2008-01-15
JP4015954B2 (ja) 2007-11-28
DK1295870T3 (da) 2008-01-28
CN1461297A (zh) 2003-12-10
ES2298358T3 (es) 2008-05-16
CA2413087A1 (fr) 2002-12-16
EP1295870B1 (fr) 2007-12-19
CY1107112T1 (el) 2012-10-24
DE60224145D1 (de) 2008-01-31
KR100535305B1 (ko) 2005-12-08
TWI241289B (en) 2005-10-11
JPWO2002083633A1 (ja) 2004-08-05
DE60224145T2 (de) 2008-12-11
US20030149105A1 (en) 2003-08-07
CA2413087C (fr) 2008-03-11
US7138140B2 (en) 2006-11-21
EP1295870A1 (fr) 2003-03-26
EP1295870A4 (fr) 2006-01-18
CN1205182C (zh) 2005-06-08
KR20030029051A (ko) 2003-04-11

Similar Documents

Publication Publication Date Title
CY1107112T1 (el) Κρυσταλλοι τοζιλικου suplatast
DZ1792A1 (fr) Une nouvelle forme de composé.
MY138452A (en) Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these
MXPA04003936A (es) Cristal en forma alfa o en forma beta de derivado de acetanilida.
KR880001226A (ko) 유용성물질함유 고상물의 제조방법
AU4469201A (en) Novel crystal form of pyrrolidylthiocarbapenem derivative
KR950010910A (ko) 내포 복합체
NO20016381D0 (no) Dinukleotidkrystaller
NO20011634L (no) Krystall av diuridintetrafosfat eller salter derav, og fremgangsmåte for fremstilling av samme og fremgangsmåte forfremstilling av nevnte forbindelse
FI955285A (fi) Suuria kaliumvetykarbonaattikiteitä ja menetelmä niiden valmistamiseksi
MXPA05010104A (es) Polvo cristalino de trihidrato de amoxicilina.
Jayaraman et al. A high-pressure Raman study of KReO4, RbReO4 and CsReO4 to 25 GPa and pressure-induced phase transitions
AU602201B2 (en) Calcium lactate-glycerol adduct, a process for its preparation and its use
HUT68779A (en) Crystall-modification of (4-cyclopropyl-6-methyl-pyrimidin-2-il)-phenyl-amin, process for its production and for its use as fungicide
CA2000184C (fr) L- et d-2-pyrrolidone-5-carboxylates de sodium trihydrates
PT1462439E (pt) Novos cristais estáveis de derivado do ácido fenilpropiónico substituído e processo para a sua produção
AU2001241140A1 (en) Novel crystal of stilbene derivative and process for producing the same
EP0894784A4 (fr) Derives d'acide 4-fluorosalicyclique et leur procede de production
JPS6434927A (en) Method for asymmetric photochemical reaction
CO4410182A1 (es) Proceso para mejorar la pureza enantiomerica de aldehidos
TH50989A (th) รูปผลึกที่ vii ของคาเบอร์โกลีน
DE69311751T2 (de) Silbernitrat, hergestellt durch ein kontinuierliches Verdampfungs-Kristallisationsverfahren

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150416